Phase 1/1B trial of the heat shock protein 90 inhibitor NVP‐AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma - Seggewiss‐Bernhardt - 2015 - Cancer -
Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth. - Abstract - Europe PMC
Luminespib - an overview | ScienceDirect Topics
Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants* - Molecular & Cellular Proteomics
Luminespib (VER-52296) | HSP90 Inhibitor | MedChemExpress
Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer - ScienceDirect
HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice | ACS Chemical Neuroscience
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
Selected structures of Hsp90 inhibitors in clinical trials. | Download Scientific Diagram
![PDF] Ganetespib: research and clinical development | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25a520c1fa08e8bd4ed3d065bbaddb983055dc78/2-Table1-1.png "PDF] Ganetespib: research and clinical development | Semantic Scholar")
PDF] Ganetespib: research and clinical development | Semantic Scholar
Sponsor Novartis Generic Drug Name Alpelisib/BYL719 and AUY922 Trial Indication(s) Advanced or metastatic gastric cancer (GC) ca
Luminespib - an overview | ScienceDirect Topics
The HSP90 Inhibitor, AUY-922, Ameliorates the Development of Nitrogen Mustard-Induced Pulmonary Fibrosis and Lung Dysfunction in
The Anticancer Drug AUY922 Generates a Proteomics Fingerprint That Is Highly Conserved among Structurally Diverse Hsp90 Inhibitors | Journal of Proteome Research
Proteomics Fingerprints of Auy922 and 17-dmag Indicate Common Mechanisms of Action for Hsp90 Inhibitors
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer | PGPM
Hsp90 phase II candidate | Vernalis Research
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells | Anticancer Research
The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage | PLOS ONE
Luminespib - an overview | ScienceDirect Topics
Frontiers | Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
Frontiers | Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
Full article: Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
Hsp90 phase II candidate | Vernalis Research
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
